QR kód

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease

Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) show a large overlap in clinical presentation, which presents diagnostic challenges. As a consequence, invasive and burdensome endoscopies are often used to distinguish between IBD and IBS. Here, we aimed to develop a noninvasive fe...

Celý popis

Uloženo v:
Hlavní autoři: R. Gacesa, A. Vich Vila, V. Collij, Z. Mujagic, A. Kurilshikov, M.D. Voskuil, E.A.M. Festen, C. Wijmenga, D.M.A.E. Jonkers, G. Dijkstra, J. Fu, A. Zhernakova, F. Imhann, R.K. Weersma
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis Group 2021-01-01
Edice:Gut Microbes
Témata:
gut microbiome
inflammatory bowel disease
biomarkers
human beta defensin 2
noninvasive diagnosis
machine learning
On-line přístup:http://dx.doi.org/10.1080/19490976.2021.1943288
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky